
specific properties that would allow for their industrial-scale
application in the food industry.
This review will first look at the information related to the
traditional use of biomolecular simulations applied for studying
food proteins and bioactive peptides and how these method-
ologies have served as a bridge between in silico and in vitro
analyses to deepen the study of the virtual structure of a
protein when encountered with complex environments, such as
those typically found in food matrices. We will also present an
in-depth introduction to MDS theory and applications and
explain why, moving forward, these molecular simulation
techniques are necessary to help predict and explain the
structural and functional dynamics of food proteins and
bioactive peptides.
2. COMMONLY USED IN SILICO METHODS
Different in silico methodologies can be used to describe the
potential use of foods and their bioactive compounds. If the
main goal is to elucidate structure−activity relationships
between bioactive molecules and their potential targets, both
bioinformatic and biomolecular simulations can be supple-
mented with other methodologies. For example, chemo-
informatic methodologies include the analysis of chemical
information derived from structural information on biomole-
cules, such as secondary metabolites, peptides, and lipids,
among others.
17
Some of these methodologies also make use of
information deposited in databases to determine the frequency
of putative bioactive peptides in the primary structure of food
proteins.
18,19
Moreover, large databases of bioactive molecules
can be used to study the chemical space or chemical
similarities against well-known drugs. In addition, the use of
artificial intelligence (AI) techniques in bioinformatics and
biomolecular simulation exemplifies the integration of different
fields under multivariate statistics, where the effect of many
variables or chemical properties determine the bioactivity
profile of specific targets.
20−22
Nevertheless, if the structure of
target bioactive compounds is unknown, different models can
be built based on the information on a molecular reference
(i.e., ligands and substrates). Such methodologies are also
known as ligand-based methods, with the most applied
computational methods being the quantitative structure−
activity relationship (QSAR), quantitative structure−property
relationship (QSPR) analysis, and pharmacophore modeling.
23
Other methods, such as iBitter-SCM, are employed to
determine the bitterness of peptides (bitterness peptide
screening, https://camt.pythonanywhere.com/iBitter-SCM)
24
using the scoring card method (SCM). In addition, in silico
screening methods are widely used to study toxins, food-borne
pathogens, and trypsin inhibitors in foods at a molecular
level.
33,34
In foods for health research, in silico methods are used on
proteins and bioactive peptides to determine different
parameters, such as their affinity to bind specifically to their
targets, their probability to be bioactive, their intestinal
stability, and their ability to be retained in the circulatory
system, among others. Table 1 lists a summary of commonly
used software tools available for the in silico analysis of
bioactive peptides. Of the many in silico methods described,
molecular docking analysis is one of the most widely used tools
in drug design research and virtual screening studies to find
novel active molecules derived from natural sources (e.g.,
plants), where this type of biomolecular simulation is used to
predict binding sites, elucidate the mechanism of molecular
recognition by simulating the spontaneous binding process of
biomolecules (e.g., proteins, carbohydrates, and lipids), and
explain their intermolecular interactions.
13
2.1. Overview of Molecular Docking Analysis in Food
Proteins and Bioactive Peptides. In the area of bioactive
peptides, molecular docking allows for characterization of the
behavior of peptides in the binding site of target proteins.
Because molecular docking is a structure-based method, it
enables it to delineate the structure−activity relationship of
peptides.
35
Overall, the molecular docking process includes
predicting the molecular orientation of a ligand within a
receptor and then calculating their complementarity inter-
action using a scoring function (i.e., binding affinity).
12
Figure
1depicts the steps taken to carry out molecular docking
analysis of a bioactive peptide. For example, once bioactive
peptides have been successfully fractionated and identified (i.e.,
sequenced) and their bioactivity has been determined through
in vitro or in vivo assays, they undergo structural preparation for
docking. Next, the ligand is prepared for established target
receptor−ligand complex structures using docking simulation
software. Finally, the analysis of the data is performed by
predicting the binding modes and affinities (i.e., scoring
functions) of a small molecule (i.e., bioactive peptide) within
the binding sites of target receptors (Figure 1).
In the case of food proteins, molecular docking has been
used mainly to study the relationship between enzymes and
substrates, which can help in the regulation of enzyme activity
in foods, as well as to study antinutritive compounds, such as
trypsin inhibitors.
13
For example, it was used to study the
binding interaction between egg white ovalbumin and
malachite green dye, a food additive with probable
carcinogenic potential, showing that the interaction between
ovalbumin and malachite occurred through hydrophobic and
van der Waals interactions.
36
Similarly, molecular docking was
used to determine that myrosinase, an enzyme found in
broccoli (Brassica oleracea var. italica), was able to catalyze the
conversion of glucosinolates to metabolites that possess health-
Table 1. Examples of Different Tool Resources Employed for the In Silico Analysis of Bioactive Peptides
a
online in silico tool prediction function webserver link reference
Peptide Ranker bioactivity potential scoring http://distilldeep.ucd.ie/PeptideRanker 25
PreAIP anti-inflammatory peptide screening http://kurata14.bio.kyutech.ac.jp/PreAIP/ 26
iDPPIV-SCM DPP-IV inhibitor peptide https://camt.pythonanywhere.com/iDPPIV-SCM 27
AntiAngioPred anti-angiogenic peptide http://crdd.osdd.net/raghava/antiangiopred/ 28
AHTPIN antihypertensive peptide http://crdd.osdd.net/raghava/ahtpin/ 29
HLP intestinal stability http://crdd.osdd.net/raghava/hlp/ 30
PlifePred plasma stability https://webs.iiitd.edu.in/raghava/plifepred/ 31
ToxinPred toxicity screening https://webs.iiitd.edu.in/raghava/toxinpred 32
a
DPP-IV = dipeptidyl peptidase-IV.
Journal of Agricultural and Food Chemistry pubs.acs.org/JAFC Review
https://doi.org/10.1021/acs.jafc.1c06110
J. Agric. Food Chem. 2022, 70, 934−943
935